Loading clinical trials...
Loading clinical trials...
Long-term Nucleoside/Nucleotide Treatment of Hepatitis B Virus HBeAg-negative Genotype D Patients and Risk of Hepatocellular Carcinoma:Evidence From the CLEO Cohort Study
Conditions
Start Date
January 1, 2000
Primary Completion Date
December 1, 2013
Completion Date
December 1, 2013
Last Updated
January 1, 2014
NCT06811116
NCT06066138
NCT07485114
NCT06345508
NCT07024641
NCT04380545
Lead Sponsor
Azienda Ospedaliera San Camillo Forlanini
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions